Related Experiment Video

Updated: Jun 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and

Ganesh Raghu, Harold R Collard, Jim J Egan

    American Journal of Respiratory and Critical Care Medicine
    |April 8, 2011
    PubMed

    Insights

    This international guideline provides evidence-based recommendations for diagnosing and managing idiopathic pulmonary fibrosis (IPF). It covers epidemiology, risk factors, diagnosis, prognosis, and treatment, emphasizing patient values in clinical decisions.

    Area of Science:

    • Pulmonology
    • Medical Guidelines

    Background:

    • Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease.
    • Current knowledge on IPF diagnosis and management requires comprehensive, evidence-based guidelines.

    Purpose of the Study:

    • To establish an international evidence-based guideline for the diagnosis and management of IPF.
    • To synthesize current knowledge on IPF, including epidemiology, risk factors, diagnosis, prognosis, and treatment.

    Main Methods:

    • Collaborative effort by major international thoracic societies.
    • Pragmatic GRADE evidence-based methodology applied to diagnosis and treatment questions.
    • Recommendations based on graded evidence quality and majority vote.

    Main Results:

    • Comprehensive sections on IPF definition, epidemiology, risk factors, diagnosis, natural history, staging, prognosis, treatment, and monitoring.
    • Graded evidence quality (high to very low) and clear recommendations (strong/weak) for diagnosis and treatment.

    Conclusions:

    • Provides a framework for clinicians to diagnose and manage IPF effectively.
    • Highlights the importance of integrating patient values and preferences into treatment decisions.
    • Represents the current state of knowledge for idiopathic pulmonary fibrosis management.

    Related Concept Videos

    Asthma-IV: Diagnostic and Management01:30

    Asthma-IV: Diagnostic and Management

    The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
    Clinical Assessment for Asthma:
    This is the first step in diagnosing and managing asthma. It includes:
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

    Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

    Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
    Medical History
    Pleural Effusion II: Symptoms and Management01:28

    Pleural Effusion II: Symptoms and Management

    Pleural Effusion Overview
    A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
    Clinical Manifestations:
    Chronic Obstructive Pulmonary Disease II: Emphysema01:23

    Chronic Obstructive Pulmonary Disease II: Emphysema

    Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
    Pulmonary Function Tests01:25

    Pulmonary Function Tests

    Pulmonary Function Tests (PFTs)
    Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
    PFTs involve using a spirometer, a...